HMGB1 and neoplasm: Cathepsins B and L are useful biomarkers for the efficacy of reovirus-mediated tumor cell killing (98), and serum high-mobility group box 1 (HMGB1) protein was reported to be a potential predictive and prognostic biomarker for adenoviruses combined with immunotherapy (99).